These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11532617)

  • 21. Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer.
    Wong R; Rondon G; Saliba RM; Shannon VR; Giralt SA; Champlin RE; Ueno NT
    Bone Marrow Transplant; 2003 Jun; 31(12):1157-63. PubMed ID: 12796796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of high dose chemotherapy with autologous peripheral hemopoietic cell transplantation in multiple sclerosis].
    Kliuzhev VM; Kovalenko PA; Rukavitsyn OA; Shamanskiĭ SV; Baziĭ NI; Ian'shina IL
    Voen Med Zh; 2002 Aug; 323(8):41-3. PubMed ID: 12379029
    [No Abstract]   [Full Text] [Related]  

  • 23. Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.
    Schulman KA; Stadtmauer EA; Reed SD; Glick HA; Goldstein LJ; Pines JM; Jackman JA; Suzuki S; Styler MJ; Crilley PA; Klumpp TR; Mangan KF; Glick JH
    Bone Marrow Transplant; 2003 Feb; 31(3):205-10. PubMed ID: 12621482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy.
    Montemurro F; Rondón G; Ueno NT; Munsell M; Gajewski JL; Champlin RE
    Bone Marrow Transplant; 2002 May; 29(10):861-6. PubMed ID: 12058236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
    Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
    Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The importance of autologous transplantation in multiple myeloma].
    Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation.
    Kim YS; Konoplev SN; Montemurro F; Hoy E; Smith TL; Rondón G; Champlin RE; Sahin AA; Ueno NT
    Clin Cancer Res; 2001 Dec; 7(12):4008-12. PubMed ID: 11751494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future prospectives in the treatment of breast cancer.
    Henney JE; DeVita VT
    Semin Oncol; 1978 Dec; 5(4):465-8. PubMed ID: 366758
    [No Abstract]   [Full Text] [Related]  

  • 29. [The Bezwoda affair].
    Armand JP
    Bull Cancer; 2000 Apr; 87(4):363-4. PubMed ID: 10858047
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of cancer with high-dose chemotherapy and autologous stem cell transplantation].
    Geisler CH; Daugaard KG; Dickmeiss E; Ifversen M; Knudsen LM
    Ugeskr Laeger; 2003 Dec; 165(50):4846-9. PubMed ID: 14716902
    [No Abstract]   [Full Text] [Related]  

  • 31. Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.
    Pedrazzoli P; Ferrante P; Kulekci A; Schiavo R; De Giorgi U; Carminati O; Marangolo M; Demirer T; Siena S; Rosti G;
    Bone Marrow Transplant; 2003 Sep; 32(5):489-94. PubMed ID: 12942095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support.
    Hensel M; Schneeweiss A; Sinn HP; Egerer G; Kornacker M; Solomayer E; Haas R; Bastert G; Ho AD
    Stem Cells; 2002; 20(1):32-40. PubMed ID: 11796920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic hematopoietic stem cell transplantation for metastatic breast cancer.
    Bishop MR
    Haematologica; 2004 May; 89(5):599-605. PubMed ID: 15136224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.
    Zander AR; Kröger N; Schmoor C; Krüger W; Möbus V; Frickhofen N; Metzner B; Schultze W; Berdel WE; Koenigsmann M; Thiel E; Wandt H; Possinger K; Trümper L; Kreienberg R; Carstensen M; Schmidt EH; Jänicke F; Schumacher M; Jonat W
    J Clin Oncol; 2004 Jun; 22(12):2273-83. PubMed ID: 15111618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dose density and dose intensity in the treatment of breast cancer].
    Saintigny P; Assouad S; Gligorov J; Selle F; Roché H; Breau JL; Morère JF; Lotz JP
    Bull Cancer; 2004 Dec; 91 Suppl 4():S244-53. PubMed ID: 15899616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer studies yield mixed results on high-dose chemotherapy with stem cell support.
    Miller SL
    Am J Health Syst Pharm; 1999 May; 56(10):939. PubMed ID: 10365714
    [No Abstract]   [Full Text] [Related]  

  • 37. Introduction: dose-intensive therapy for adult malignancies.
    Weiss RB
    Semin Oncol; 1999 Feb; 26(1):1-5. PubMed ID: 10073557
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reduced-intensity allogeneic hematopoietic stem cell transplantation (mini-transplantation) for solid tumors].
    Makimoto A; Takaue Y
    Gan To Kagaku Ryoho; 2002 Jun; 29(6):835-41. PubMed ID: 12090032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer.
    Rizzo JD; Williams S; Wu JT; Pecora AL; Lazarus HM; Bolwell B; Fields KK; Gale RP; Elfenbein G; Horowitz MM; Antman KH
    Bone Marrow Transplant; 2003 Jul; 32(2):151-5. PubMed ID: 12838279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
    Porrata LF; Ingle JN; Litzow MR; Geyer S; Markovic SN
    Bone Marrow Transplant; 2001 Nov; 28(9):865-71. PubMed ID: 11781647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.